New Mountain Capital-backed health tech Datavant is working with JPMorgan on a strategic review, Axios Pro has learned. NMC’s exit strategy for its health tech assets is coming into focus after a planned portfolio sale to former private equity chief Matt Holt collapsed.
Read the full article: NMC-Backed Datavant Working with JPM on Strategic Review //
Source: https://www.axios.com/pro/health-tech-deals/2026/07/31/datavant-ipo-recap-new-mountain-capital